Results 121 to 130 of about 7,238,985 (145)

Trends in EU regulatory assessment of oncology medicines. [PDF]

ESMO Open
Pabsch T, Pignatti F, Day F, Sepodes B, Enzmann H.   +4 more
europepmc   +1 more source

Securing raw materials, reagents, and consumable supplies in the academic bioproduction UNITC network: because the chain is only as strong as its weakest link. [PDF]

Bone Marrow Transplant
Chartral U, Galaine J, Giverne C, Auxenfans C, Reppel L, Marton C, Thiant S, Clémenceau B, Derenne S, Sabatier F, Veran J, Moisan A, Rouard H, Tertrais K, Dachy G, Demerle C, Calmels B, Chabannon C, Forcade E, Viel S, Bensoussan D, de Vos J, Galy A, De Oliveira C, Boucher H, Magrin E, Fabreguettes JR, Cavazzana M, Larghero J, Deschamps M, Martinet J, Boyer O, Ferrand C, Yakoub-Agha I, Diana JS.   +34 more
europepmc   +1 more source

Pathing the way from regulatory approval to market access for gene therapy products (GTPs): An integrative review in the US, EU5, Japan and China. [PDF]

Regen Ther
Shi J, Hu H, Ung COL.
europepmc   +1 more source

Building a gene editing lexicon: a model for rare and inherited disorders. [PDF]

Gene Ther
Valentino LA, Hermans C, Coffin D, Miesbach W, Mancuso ME, Unzu C, Jones M, Gutstein DE, McKeown W, Kessler CM.   +9 more
europepmc   +1 more source

The Landscape of Advanced Therapy Medicinal Products in Slovenian Transfusion Medicine: A Review of Past and Future Outlook. [PDF]

Transfus Med Hemother
Švajger U, Poženel P, Rožman PJ, Cukjati M.   +3 more
europepmc   +1 more source

Editorial: Potency assays for use in manufacturing cellular immunotherapies. [PDF]

Front Immunol
Phinney DG, Lee RH, Johnstone BH.
europepmc   +1 more source

Advanced Therapy Medicinal Products: What's in a Name? [PDF]

Journal of Pharmaceutical Sciences, 2020
In this commentary I briefly discuss the term advanced therapy medicinal products (ATMPs). The last two words, medicinal products, correctly indicate that we are dealing with medicines.
Wim Jiskoot
exaly   +2 more sources

Advanced therapy medicinal products: current and future perspectives

Journal of Market Access & Health Policy, 2016
Background: Advanced therapy medicinal products (ATMPs) are innovative therapies that encompass gene therapy, somatic cell therapy, and tissue-engineered products. These therapies are expected to bring important health benefits, but also to substantially
Mondher Toumi, Pascal Auquier, Cecile Rémuzat   +2 more
exaly   +2 more sources

The clinical toxicity of advanced therapy medicinal products

British Journal of Clinical Pharmacology
\ua9 2025 British Pharmacological Society. Aims: Advanced Therapy Medicinal Products (ATMPs) use genes, tissues or cells to offer transformative treatments for a range of diseases.
Henderson FJH, Hill SL
exaly   +5 more sources